Mibiton

BioConnection B.V., based in Oss, the Netherlands, specializes in biopharmaceutical development and manufacturing services for small and medium-sized biopharmaceutical companies. Established in 2005, the company offers a comprehensive range of services, including clinical fill and finish, formulation development, and the manufacturing of active biopharmaceutical ingredients. BioConnection provides access to both small-scale clinical batch production and large-scale commercial facilities, ensuring compliance with good manufacturing practices (GMP). The company leverages a robust network of skilled suppliers and partners, including Merck & Co., to deliver expertise in the complete clinical development process. This support is particularly beneficial for young biopharmaceutical firms that may lack the facilities or experience necessary for effective drug development. BioConnection serves various needs, from personalized medications to clinical trial materials, making it a versatile partner in the biopharmaceutical landscape.

Developer of tumor localization technology designed to improve care for cancer patients. The company's technology uses a tiny implanted magnetic seed to precisely mark the tumor and a detection probe to accurately locate the seed during surgery, enabling patients to receive affordable cancerous tumor surgery and improved surgical care.